New Guidelines for Managing Blood Cancers in Pregnancy
Macquarie University
About 12.5 pregnancies per 100,000 are affected by blood cancers, and their incidence has been rising
CAR T-cell therapy recipients with refractory lymphoma showed poorer treatment outcomes when treated with bendamustine
Fighting relapsed/refractory lymphoma during pregnancy requires critical decision-making from patients and providers